AJP - Renal Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 297: F1647-F1655, 2009. First published September 23, 2009; doi:10.1152/ajprenal.00082.2009
0363-6127/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/6/F1647    most recent
00082.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Carraro-Lacroix, L. R.
Right arrow Articles by Girardi, A. C. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carraro-Lacroix, L. R.
Right arrow Articles by Girardi, A. C. C.

Regulation of Na+/H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells

Luciene R. Carraro-Lacroix,1,3 Gerhard Malnic,1 and Adriana C. C. Girardi1,2

1Department of Physiology and Biophysics, Institute of Biomedical Sciences; ; 2Heart Institute (InCor), Medical School, University of São Paulo, and ; 3Department of Physiology, Federal University of São Paulo, São Paulo, Brazil

Submitted February 12, 2009 ; accepted in final form September 17, 2009

The gut incretin hormone glucagon-like peptide 1 (GLP-1) is released in response to ingested nutrients and enhances insulin secretion. In addition to its insulinotropic properties, GLP-1 has been shown to have natriuretic actions paralleled by a diminished proton secretion. We therefore studied the role of the GLP-1 receptor agonist exendin-4 in modulating the activity of Na+/H+ exchanger NHE3 in LLC-PK1 cells. We found that NHE3-mediated Na+-dependent intracellular pH (pHi) recovery decreased ~50% after 30-min treatment with 1 nM exendin-4. Pharmacological inhibitors and cAMP analogs that selectively activate protein kinase A (PKA) or the exchange protein directly activated by cAMP (EPAC) demonstrated that regulation of NHE3 activity by exendin-4 requires activation of both cAMP downstream effectors. This conclusion was based on the following observations: 1) the PKA antagonist H-89 completely prevented the effect of the PKA activator but only partially blocked the exendin-4-induced NHE3 inhibition; 2) the MEK1/2 inhibitor U-0126 abolished the effect of the EPAC activator but only diminished the exendin-4-induced NHE3 inhibition; 3) combination of H-89 and U-0126 fully prevented the effect of exendin-4 on NHE3; 4) no additive effect in the inhibition of NHE3 activity was observed when exendin-4, PKA, and EPAC activators were used together. Mechanistically, the inhibitory effect of exendin-4 on pHi recovery was associated with an increase of NHE3 phosphorylation. Conversely, this inhibition took place without changes in the surface expression of the transporter. We conclude that GLP-1 receptor agonists modulate sodium homeostasis in the kidney, most likely by affecting NHE3 activity.

dipeptidyl peptidase IV; sodium reabsorption; intracellular pH; protein kinase A; exchange protein directly activated by cAMP



Address for reprint requests and other correspondence: A. C. C. Girardi, Institute of Heart—Laboratory of Genetics and Molecular Cardiology, Univ. of São Paulo Medical School, Avenida Dr. Enéas de Carvalho Aguiar, 44, 10° andar, Bloco II, 05403-900 São Paulo, SP, Brazil (e-mail: adriana.girardi{at}incor.usp.br).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.